← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Regranion, Llc
Mount Pleasant, SC
$1,477,701
Total funding
2
Grants
Funding over time
peak $654K · FY2017–20$1M$750K$500K$250K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$1,477,701 · 2
By mechanism
R44$1,225,570 · 1
R43$252,131 · 1
Investigators at Regranion, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
A Novel Topical HSP90 Inhibitor (CTXT-102) in the Treatment of Mild to Moderate Plaque Psoriasis$654,034
R44 · FY2017 · AR
A Novel Topical HSP90 Inhibitor (CTXT-102) in the Treatment of Mild to Moderate Plaque Psoriasis$571,536
R44 · FY2018 · AR
Novel small molecule HSP90 inhibitor for the management of atopic dermatitis$252,131
R43 · FY2020 · AR